Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 USD | +1.55% | +2.83% | +19.63% |
Financials (USD)
Sales 2024 * | 29.73M | Sales 2025 * | 18.47M | Capitalization | 90.73M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -64M | EV / Sales 2024 * | 0.09 x |
Net cash position 2024 * | 88.17M | Net cash position 2025 * | 64.24M | EV / Sales 2025 * | 1.43 x |
P/E ratio 2024 * |
-2.98
x | P/E ratio 2025 * |
-2.29
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.62% |
Latest transcript on Precision BioSciences, Inc.
1 day | +1.55% | ||
1 week | +2.83% | ||
Current month | +1.55% | ||
1 month | +20.85% | ||
3 months | +2.99% | ||
6 months | +19.63% | ||
Current year | +19.63% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 46 | 21-10-14 |
Jeff Smith
FOU | Founder | - | 06-01-25 |
John Kelly
DFI | Director of Finance/CFO | 57 | 20-10-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Buehler
CHM | Chairman | 66 | 19-11-07 |
Geno Germano
BRD | Director/Board Member | 63 | 20-03-09 |
Samuel Wadsworth
BRD | Director/Board Member | 75 | 21-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.16% | 2 M€ | -25.75% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 13.1 | +1.55% | 24,888 |
24-05-31 | 12.9 | +0.62% | 22,967 |
24-05-30 | 12.82 | +4.48% | 87,651 |
24-05-29 | 12.27 | -3.00% | 32,267 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.63% | 89.34M | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- DTIL Stock